UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

Care for the Psychological Status of Frontline Medical Staff Fighting Against Coronavirus Disease 2019 (COVID-19)

Clinical infectious diseases, 2020-12, Vol.71 (12), p.3268-3269

2020

Volltextzugriff (PDF)

Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis

Psychopharmacology, 2021-09, Vol.238 (9), p.2449-2457

2021

Volltextzugriff (PDF)

Autism spectrum disorder and severe social impairment associated with elevated plasma interleukin-8

Pediatric research, 2021-02, Vol.89 (3), p.591-597

2021

Volltextzugriff (PDF)

Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia

Frontiers in neuroscience, 2021-04, Vol.15, p.641047-641047

2021

Volltextzugriff (PDF)

Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs/ JAK-STAT signaling pathway

BMC psychiatry, 2023-07, Vol.23 (1), p.514-514, Article 514

2023

Volltextzugriff (PDF)

Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats

PloS one, 2014-04, Vol.9 (4), p.e93966

2014

Volltextzugriff (PDF)

The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial

Translational psychiatry, 2022-05, Vol.12 (1), p.185-185, Article 185

2022

Volltextzugriff (PDF)

Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine

Heliyon, 2024-04, Vol.10 (7), p.e28832-e28832, Article e28832

2024

Volltextzugriff (PDF)

Risk factors for osteoporosis in chronic schizophrenia on long-term treatment with antipsychotics: a cross-sectional study

BMC psychiatry, 2023-06, Vol.23 (1), p.454-454, Article 454

2023

Volltextzugriff (PDF)

Effects of sulforaphane on cognitive function in patients with frontal brain damage: study protocol for a randomised controlled trial

BMJ open, 2020-10, Vol.10 (10), p.e037543-e037543

2020

Volltextzugriff (PDF)

Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial

Lipids in health and disease, 2024-07, Vol.23 (1), p.225-11, Article 225

2024

Volltextzugriff (PDF)

PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients

Psychopharmacology, 2022, Vol.239 (1), p.83-91

2022

Volltextzugriff (PDF)

Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis

PloS one, 2015-04, Vol.10 (4), p.e0123373-e0123373

2015

Volltextzugriff (PDF)

The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls

Schizophrenia research, 2013-10, Vol.150 (1), p.157-162

2013

Volltextzugriff (PDF)

The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial

Translational psychiatry, 2024-01, Vol.14 (1), p.61-8, Article 61

2024

Volltextzugriff (PDF)

Diagnostic Stability in Psychiatric Patients From Hospital Admission to Discharge: A 10-Year Retrospective Study

PSYCHIATRY INVESTIGATION, 2023, 20(5), , pp.461-470

2023

Volltextzugriff (PDF)

Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments

BMC psychiatry, 2022-03, Vol.22 (1), p.210-210, Article 210

2022

Volltextzugriff (PDF)

Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial

BMC medicine, 2023-07, Vol.21 (1), p.263-263, Article 263

2023

Volltextzugriff (PDF)

Sex Differences in Psychological Status and Fatigue of Frontline Staff After the COVID-19 Outbreak in China: A Cross-Sectional Study

Frontiers in psychology, 2021-09, Vol.12, p.676307-676307

2021

Volltextzugriff (PDF)

Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia

Frontiers in neuroscience, 2018-05, Vol.12, p.296-296

2018

Volltextzugriff (PDF)

Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone

BMC psychiatry, 2021-02, Vol.21 (1), p.70-70, Article 70

2021

Volltextzugriff (PDF)

Association between olanzapine concentration and metabolic dysfunction in drug-naive and chronic patients: similarities and differences

Schizophrenia (Heidelberg, Germany), 2022-02, Vol.8 (1), p.9-9, Article 9

2022

Volltextzugriff (PDF)

Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia

Translational psychiatry, 2024-02, Vol.14 (1), p.79-79, Article 79

2024

Volltextzugriff (PDF)

Anesthesia, sex and miscarriage history may influence the association between cesarean delivery and autism spectrum disorder

BMC pediatrics, 2021-02, Vol.21 (1), p.62-62, Article 62

2021

Volltextzugriff (PDF)

Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex

Translational psychiatry, 2023-10, Vol.13 (1), p.315-315, Article 315

2023

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Care for the Psychological Status of Frontline Medical Staff Fighting Against Coronavirus Disease 2019 (COVID-19)

Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis

Autism spectrum disorder and severe social impairment associated with elevated plasma interleukin-8

Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia

Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs/ JAK-STAT signaling pathway

Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats

The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial

Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine

Risk factors for osteoporosis in chronic schizophrenia on long-term treatment with antipsychotics: a cross-sectional study

Effects of sulforaphane on cognitive function in patients with frontal brain damage: study protocol for a randomised controlled trial

Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial

PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients

Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis

The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls

The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial

Diagnostic Stability in Psychiatric Patients From Hospital Admission to Discharge: A 10-Year Retrospective Study

Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments

Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial

Sex Differences in Psychological Status and Fatigue of Frontline Staff After the COVID-19 Outbreak in China: A Cross-Sectional Study

Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia

Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone

Association between olanzapine concentration and metabolic dysfunction in drug-naive and chronic patients: similarities and differences

Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia

Anesthesia, sex and miscarriage history may influence the association between cesarean delivery and autism spectrum disorder

Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex

Suchergebnisse filtern